Clinical Trials Browser

Phase 1 × picropodophyllin × Clear all

NCT01466647 2012-11-12

A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT01062620 2011-09-15

A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumors